Categories: News

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Magnite, Inc. (MGNI) for Possible Securities Law Violations, Encourages MGNI Investors and Persons Who May be Able to Assist to Contact its Attorneys Now

SAN FRANCISCO, Jan. 08, 2021 (GLOBE NEWSWIRE) — Hagens Berman notifies investors in Magnite, Inc. (NASDAQ: MGNI) of the firm’s investigation into possible securities law violations. Magnite investors are encouraged to submit their losses now.   The firm also encourages persons who may be able to assist the investigation to contact the firm.

Visit: www.hbsslaw.com/investor-fraud/MGNI
Contact An Attorney Now: MGNI@hbsslaw.com
                                              844-916-0895

Magnite, Inc. (MGNI) Investigation:

The investigation centers on whether Magnite misled investors about the company’s financial reporting, connected TV (“CTV”) inventory, and other matters after the company was formed in 2020 through the merger of Telaria Inc. and Rubicon Project Inc.

On Jan. 7, 2020, research firm Spruce Point Capital Management published a report stating, “[w]e believe investors are being misguided by Magnite’s growth prospects, and see 25%-50% downside.” According to Spruce Point “[m]ultiple customer interviews all tell us that Magnite does not have much quality CTV inventory to currently sell.”   Spruce Point also “believes that Magnite’s financial reporting does not accurately reflect the economics of its business, and may be concealing the struggles of Telaria.”

In response, the price of Magnite shares fell sharply lower.

“We’re focused on investor losses and whether Magnite has been masking business challenges with inaccurate financial reporting,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you are a Magnite investor or have information that may assist our investigation, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding Magnite should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email MGNI@hbsslaw.com.

About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation.   More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 844-916-0895

Staff

Recent Posts

Restart Life Sciences Signs Binding LOI to Acquire The Holy Crap Foods Portfolio of Brands and Manufacturing Plant

Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…

16 minutes ago

Functional Brands Inc. Launches Kirkman’s(R) Skin, Beauty & Anti-Aging Bundle: A Science-Backed Approach to Radiant, Resilient Skin

Comprehensive Formula Featuring Reduced Glutathione, Zinc Cream, Biotin, and Grapefruit Seed ExtractLake Oswego, Oregon--(Newsfile Corp.…

16 minutes ago

CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities

Houston, Texas--(Newsfile Corp. - December 22, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) (CBIH) announces…

1 hour ago

XRP Healthcare® Secures Global Trademark Protection at the Intersection of Healthcare Services and XRP-Powered Payments

Multi-jurisdiction trademark coverage reinforces XRP Healthcare's position across digital health, pharmacy networks, and XRP-based payment…

2 hours ago

Black Book Poll: “Governed AI” Emerges as the Deciding Factor in 2026 NHS Procurement

Respondents report approvals and evaluation readiness are now the bottlenecks driving demand for reusable safety…

2 hours ago

Hemogenyx Pharmaceuticals PLC Announces Update on Admission of Shares

LONDON, UK / ACCESS Newswire / December 22, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the…

2 hours ago